{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:55:01Z","timestamp":1788346501892,"version":"build-2803163510"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01HL132819"],"award-info":[{"award-number":["P01HL132819"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL135575"],"award-info":[{"award-number":["R01HL135575"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP5OD019892"],"award-info":[{"award-number":["DP5OD019892"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.tracli.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T22:13:22Z","timestamp":1553552002000},"page":"130-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion"],"prefix":"10.1016","volume":"26","author":[{"given":"Satheesh","family":"Chonat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Zerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Jajosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne E.M.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra D.","family":"Josephson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Roback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2019.03.002_bib0430","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2019.03.002_bib0435","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2019.03.002_bib0440","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ajh.23877","article-title":"Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy","volume":"90","author":"Beverung","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0445","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bjh.12061","article-title":"Challenges of alloimmunization in patients with haemoglobinopathies","volume":"159","author":"Chou","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0450","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.03.002_bib0455","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tmrv.2007.12.002","article-title":"Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services","volume":"22","author":"Hillyer","year":"2008","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2019.03.002_bib0460","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.03.002_bib0465","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","article-title":"Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood","volume":"322","author":"Vichinsky","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2019.03.002_bib0470","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/trf.14282","article-title":"Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia","volume":"5","author":"Yee","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0475","doi-asserted-by":"crossref","DOI":"10.1111\/trf.14610","article-title":"Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapy","author":"Yee","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0480","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3324\/haematol.2017.175752","article-title":"Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome","volume":"102","author":"Singhal","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2019.03.002_bib0485","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1537-2995.2001.41091086.x","article-title":"Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial","volume":"41","author":"Vichinsky","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0490","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1586\/14737159.2015.1086646","article-title":"Considerations of red blood cell molecular testing in transfusion medicine","volume":"15","author":"Svensson","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.tracli.2019.03.002_bib0495","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/MOH.0000000000000469","article-title":"The role of genomics in transfusion medicine","volume":"25","author":"Wheeler","year":"2018","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0500","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.transci.2010.12.014","article-title":"The role of molecular immunohematology in sickle cell disease","volume":"44","author":"Chou","year":"2011","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2019.03.002_bib0505","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1537-2995.2011.03288.x","article-title":"Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease","volume":"52","author":"Wilkinson","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0510","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/vox.12086","article-title":"Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing","volume":"106","author":"Matteocci","year":"2014","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2019.03.002_bib0515","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.03.002_bib0520","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bjh.13123","article-title":"Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease","volume":"168","author":"Fasano","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0525","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1182\/blood-2013-03-488874","article-title":"Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus\/newborn in a murine model","volume":"122","author":"Stowell","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.03.002_bib0530","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1537-2995.2006.00946.x","article-title":"Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells","volume":"46","author":"Hendrickson","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0535","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/trf.12217","article-title":"Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies","volume":"54","author":"Stowell","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0540","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000369079","article-title":"A Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci among Red Blood Cell Transfusion Recipients with Sickle Cell Disease","volume":"41","author":"Hanchard","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2019.03.002_bib0545","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood-2017-05-784876","article-title":"Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease","volume":"130","author":"Meinderts","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.03.002_bib0550","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/trf.12940","article-title":"Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival","volume":"55","author":"Telen","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0555","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/trf.13379","article-title":"Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series","volume":"56","author":"Nickel","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0560","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MOH.0b013e32833e5ac7","article-title":"Minority donation in the United States: challenges and needs","volume":"17","author":"Shaz","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0565","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/trf.13037","article-title":"Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease","volume":"55","author":"Karafin","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0570","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1182\/blood-2018-05-851360","article-title":"RH genotype matching for transfusion support in sickle cell disease","volume":"132","author":"Chou","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.03.002_bib0575","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/trf.13416","article-title":"Comprehensive red blood cell and platelet antigen prediction from whole genome sequencing: proof of principle","volume":"56","author":"Lane","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0580","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/S2352-3026(18)30053-X","article-title":"Automated typing of red blood cell and platelet antigens: a whole-genome sequencing study","volume":"5","author":"Lane","year":"2018","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0585","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1537-2995.2009.02462.x","article-title":"Toward extended phenotype matching: a new operational paradigm for the transfusion service","volume":"50","author":"Klapper","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0590","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5858\/arpa.2016-0277-SA","article-title":"Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience","volume":"141","author":"Fasano","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.tracli.2019.03.002_bib0595","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/trf.12987","article-title":"Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease","volume":"55","author":"Casas","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0600","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/trf.13611","article-title":"Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients","volume":"56","author":"Ibanez","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0605","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/trf.15010","article-title":"Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease","volume":"59","author":"Dean","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0610","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ajh.24908","article-title":"Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease","volume":"92","author":"Narbey","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0615","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ajh.24460","article-title":"Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes","volume":"91","author":"Habibi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0620","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/bjh.13339","article-title":"Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience","volume":"169","author":"Vidler","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0625","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1309\/AJCP47QAAXTOZEKJ","article-title":"A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease","volume":"141","author":"Harm","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0630","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/ajh.24537","article-title":"A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease","volume":"91","author":"Mekontso Dessap","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0635","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1537-2995.1997.37497265337.x","article-title":"Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients\u2019 red cells","volume":"37","author":"King","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0640","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1537-2995.2008.01693.x","article-title":"Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review","volume":"48","author":"Win","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0645","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/ehm.09.2","article-title":"Hyperhemolysis syndrome in sickle cell disease","volume":"2","author":"Win","year":"2009","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0650","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1542\/peds.111.6.e661","article-title":"Delayed hemolytic transfusion reaction\/hyperhemolysis syndrome in children with sickle cell disease","volume":"111","author":"Talano","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.tracli.2019.03.002_bib0655","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1537-2995.2009.02199.x","article-title":"Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death","volume":"49","author":"Chadebech","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0660","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1537-2995.2002.00007.x","article-title":"Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions","volume":"42","author":"Aygun","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0665","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/bjh.13339","article-title":"Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience","volume":"169","author":"Vidler","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0670","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2015-09-669770","article-title":"Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients","volume":"127","author":"Dumas","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.03.002_bib0675","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.3324\/haematol.2018.194670","article-title":"Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease","volume":"103","author":"Chonat","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2019.03.002_bib0680","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.03.002_bib0685","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.13494","article-title":"How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease","volume":"170","author":"Gardner","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0690","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tracli.2017.05.016","article-title":"Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment","volume":"24","author":"Pirenne","year":"2017","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0695","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.3324\/haematol.2014.114561","article-title":"Treatment of autoimmune hemolytic anemias","volume":"99","author":"Zanella","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2019.03.002_bib0700","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2010-03-259325","article-title":"How I treat autoimmune hemolytic anemias in adults","volume":"116","author":"Lechner","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.03.002_bib0705","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2036.1996.22164025.x","article-title":"Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies","volume":"10","author":"Brattsand","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.tracli.2019.03.002_bib0710","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1538-7836.2009.03420.x","article-title":"New insight into the mechanism of action of IVIg: the role of dendritic cells","volume":"7","author":"Crow","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tracli.2019.03.002_bib0715","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1398-9995.2003.00239.x","article-title":"IVIG \u2013 mechanisms of action","volume":"58","author":"Simon","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.tracli.2019.03.002_bib0720","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2009-09-242917","article-title":"Successful treatment of IgM-mediated autoimmune hemolytic anemia with bortezomib","volume":"115","author":"Carson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.03.002_bib0725","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/trf.12815","article-title":"Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature","volume":"55","author":"Hosoba","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0730","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.tracli.2019.03.002_bib0735","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/bmt.2008.312","article-title":"Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade)","volume":"43","author":"Arpinati","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tracli.2019.03.002_bib0740","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/TP.0b013e3182081333","article-title":"The impact of proteasome inhibition on alloantibody-producing plasma cells in vivo","volume":"91","author":"Diwan","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.tracli.2019.03.002_bib0745","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood-2014-09-600411","article-title":"Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS","volume":"125","author":"Cofiell","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.03.002_bib0750","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2019.03.002_bib0755","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1423-0410.1995.tb00373.x","article-title":"Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction","volume":"69","author":"Cullis","year":"1995","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2019.03.002_bib0760","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tmrv.2015.06.001","article-title":"Hyperhemolysis in Patients With Hemoglobinopathies: A Single-Center Experience and Review of the Literature","volume":"29","author":"Danaee","year":"2015","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2019.03.002_bib0765","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/trf.12090","article-title":"Immunoglobulin-resistant delayed hemolytic transfusion reaction treated with rituximab in an adult sickle cell patient","volume":"53","author":"Delmonte","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0770","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1525-1578(10)60658-7","article-title":"Human leukocyte antigen gene polymorphism and the histocompatibility laboratory","volume":"3","author":"Williams","year":"2001","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.tracli.2019.03.002_bib0775","series-title":"The Blood Group Antigen FactsBook","author":"Reid","year":"2012"},{"key":"10.1016\/j.tracli.2019.03.002_bib0780","doi-asserted-by":"crossref","first-page":"307093","DOI":"10.1155\/2012\/307093","article-title":"Initiation and regulation of complement during hemolytic transfusion reactions","volume":"2012","author":"Stowell","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0785","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2141.1984.tb01268.x","article-title":"In vitro determination of red cell alloantibody significance using an assay of monocyte-macrophage interaction with sensitized erythrocytes","volume":"56","author":"Branch","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0790","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1537-2995.1981.21582040822.x","article-title":"The detection of clinically significant erythrocyte alloantibodies using a human mononuclear phagocyte assay","volume":"21","author":"Schanfield","year":"1981","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0795","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1537-2995.2012.03910.x","article-title":"Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion","volume":"53","author":"Liepkalns","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0800","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1111\/j.1537-2995.2012.03647.x","article-title":"Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcgamma receptors in a murine model","volume":"52","author":"Liepkalns","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0805","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1182\/blood-2006-08-040139","article-title":"Mouse models of IgG- and IgM-mediated hemolysis","volume":"109","author":"Schirmer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.03.002_bib0810","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2008-01-132092","article-title":"Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions","volume":"112","author":"Hod","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2019.03.002_bib0815","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.4049\/jimmunol.1300885","article-title":"Antigen modulation confers protection to red blood cells from antibody through Fcgamma receptor ligation","volume":"191","author":"Stowell","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.tracli.2019.03.002_bib0820","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1182\/bloodadvances.2018018408","article-title":"Antibody-mediated immune suppression by antigen modulation is antigen-specific","volume":"2","author":"Maier","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.tracli.2019.03.002_bib0825","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96910","article-title":"Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles","volume":"3","author":"Merle","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.tracli.2019.03.002_bib0830","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121631","article-title":"Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses","volume":"3","author":"Mener","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.tracli.2019.03.002_bib0835","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1111\/trf.14288","article-title":"B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice","volume":"57","author":"Gibb","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2019.03.002_bib0840","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/bloodadvances.2017010124","article-title":"Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice","volume":"2","author":"Patel","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.tracli.2019.03.002_bib0845","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.20151720","article-title":"Bridging channel dendritic cells induce immunity to transfused red blood cells","volume":"213","author":"Calabro","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.tracli.2019.03.002_bib0850","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3389\/fimmu.2018.02516","article-title":"Marginal Zone B Cells Induce Alloantibody Formation Following RBC Transfusion","volume":"9","author":"Patel","year":"2018","journal-title":"Front Immunol"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782019300400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782019300400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:38:00Z","timestamp":1778593080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782019300400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1246782019300400"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2019.03.002","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}